Consumer Information for: IFEX
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
IFEX (ifosfamide) is used to treat:
- soft tissue cancers
- cancer of the pancreas in patients who have had prior cancer treatments
- Advanced or recurrent cancer of the cervix alone or in combination with cisplatin or bleomycin
What it does
Ifosfamide interferes with the growth of cancer cells and slows their growth and spread in the body. Ifosfamide may also affect the growth of normal body cells, leading to undesirable side effects.
When it should not be used
IFEX should not be used if you have:
- urinary tract disease (obstructions to the urine flow (difficulty with urination); bladder inflammation)
- severe suppression of bone marrow function
- severe kidney problems
- severe liver problems
- active infection/suppressed immune system
- hardening of the artery walls in the brain
- allergy to ifosfamide
What the medicinal ingredient is
Ifosfamide
What the non-medicinal ingredients are
There are no nonmedicinal ingredients in IFEX.
What dosage form it comes in
IFEX is available as a sterile powder supplied in 1 g and 3 g vials. It is reconstituted and further diluted for intravenous infusion.
Warnings and precautions
Serious Warnings and Precautions
IFEX should be used under the supervision of a doctor
experienced with drugs used to treat cancer.
Serious side effects with IFEX include:
- Urotoxic side effects (on the kidneys and urinary bladder), especially hemorrhagic cystitis (inflammation and bleeding inside the bladder). IFEX should always be used with a drug called mesna that helps to prevent hemorrhagic cystitis.
- A severe decrease in the production of blood cells (myelosuppression)
- Neurotoxicity such as confusion and coma
- Central Nervous System toxicities can be severe and result in encephalopathy (abnormal brain function) and death
- Rarely, serious lung diseases such as interstitial pneumonitis, pulmonary fibrosis
Certain medications can affect the blood level of IFEX, and may increase the risk of having serious side effects.
BEFORE you use IFEX talk to your doctor or pharmacist if you have any of the following conditions:
- Previously received radiation treatment, or any cancer treatment that destroys or damages body cells (cytotoxicity);
- Cancer that has spread to the brain;
- Low white blood cell count, or cancer that has spread to the bone marrow;
- Liver problems;
- Kidney problems;
- Heart problems;
- Lung problems;
- Infections, or bladder infection (cystitis);
- Disorder of the nervous system;
- Surgery or had one in the previous 2 weeks. IFEX may prevent normal wound healing;
- Pregnant or planning to become pregnant;
- Breast feeding.
IFEX may cause other types of cancer.IFEX may cause harm to
an unborn baby. Female patients should use an effective birth
control method while using IFEX. Male patients should not father
a child while using IFEX and for up to 6 months after the last
dose of IFEX.
Do not breastfeed while using IFEX, the drug can get into the
breast milk, and therefore, into the baby.
Interactions with this medication
Before and while taking IFEX, you should always tell your doctor or pharmacist about other medications, including those you can buy without a prescription. The following drugs or procedures may interact with IFEX:
- Alcohol;
- Antibiotics (aminoglycosides);
- Anticoagulant such as Warfarin;
- Antidepressants including St. John’s Wort;
- Antihistamines;
- Anti-epileptics (phenytoin, carbamazepine);
- Anti-fungal medications (ketoconazole, fluconazole);
- Anti-viral medications;
- Medications for high blood pressure (ACE inhibitors);
- Medications to treat heart problems (amiodarone);
- Corticosteroids;
- Medications to prevent vomiting (aprepitant);
- Medication to stimulate the bone marrow;
- Medications to treat cancers (docetaxel, cisplatin);
- Sedatives;
- Natalizumab (or Tysabri for multiple sclerosis);
- Vaccines, especially live-vaccines;
- Previous irradiation of the cardiac region and urinary bladder area.
Proper use of this medication
Usual Dose
Your doctor will determine what dose of IFEX is right for you and
how often you should receive it.
Usual dose: 2000 – 2400 mg/m2 body surface area per day given
as an intravenous (into the vein) infusion over a period of a
minimum of 30 minutes, on 5 consecutive days. This 5-day
treatment is called a treatment cycle.
The administration of high single dose infusions is feasible up to
5000-8000 mg/m2/24 h under protection of continuous mesna
infusion to reduce the risk of urotoxicity.
The treatment cycle should be repeated every 3-4 weeks.
IFEX should always be given with mesna to prevent bladder
problems. It is also important to drink extra fluids to help prevent
kidney and bladder problems.
Overdose
Missed Dose
If you miss your scheduled treatment, contact your doctor or nurse as soon as possible to schedule your next treatment.
Side effects and what to do about them
Ifosfamide can sometimes cause unwanted effects such as blood problems, loss of hair, and problems with the bladder. Also, because of the way the drug acts on the body, there is a chance that it might cause other unwanted effects that may not occur until months or years later. These may include certain types of cancer, such as leukemia. Discuss these possible effects with your doctor.
Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drug and call your doctor or pharmacist |
---|---|---|---|
Very Common | |||
Anemia | ✔ | ||
Kidney problems | ✔ | ||
Blood in Urine | ✔ | ||
Central Nervous System Troubles* | ✔ | ||
Loss of hair | ✔ | ||
Low platelet count | ✔ | ||
Low white cell count | ✔ | ||
Nausea/Vomiting | ✔ | ||
Urinary Problems | ✔ | ||
Common | |||
Fever or fever with low white cell count | ✔ | ||
Infection | ✔ | ||
Liver problems | ✔ | ||
Loss of Appetite | ✔ | ||
Vein inflammation | ✔ | ||
Uncommon | |||
Diarrhea | ✔ | ||
Fatigue | ✔ | ||
Heart troubles | ✔ | ||
Low blood pressure | ✔ | ||
Malaise | ✔ | ||
Mouth inflammation | ✔ | ||
Papular rash | ✔ | ||
Peripheral neuropathy** | ✔ | ||
Skin inflammation | ✔ |
** For example, numbness of the hands and feet.
This is not a complete list of side effects. For any unexpected effects while taking IFEX, contact your doctor or pharmacist.
How to store
Store at controlled room temperature (20° to 25° C). Protect from temperatures above 30 °C.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full product monograph, prepared for
health professionals can be obtained by contacting the sponsor,
Baxter Corporation, at:
QUESTIONS OR CONCERNS
Baxter Corporation
Mississauga, CANADA L5N 0C2
1-888-719-9955
This leaflet was prepared by Baxter Corporation.
Last revised: June 27, 2018
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
PREVNAR 13 | 02335204 | PFIZER CANADA ULC | CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN 34 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B 4.4 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V 2.2 MCG / 0.5 ML |